B. Foss-Nieradko, M. Franaszczyk, M. Śpiewak, A. Oreziak, R. Płoski, Z. Bilińska
{"title":"新型截短型假丝蛋白突变是一个家族心脏性猝死的潜在原因。","authors":"B. Foss-Nieradko, M. Franaszczyk, M. Śpiewak, A. Oreziak, R. Płoski, Z. Bilińska","doi":"10.20452/pamw.3567","DOIUrl":null,"url":null,"abstract":"704 available family members (mother and sister) and revealed no abnormalities. A genetic study was performed to gain insight into SCD in the family and identify family members at potential risk. DNA was extracted from peripheral blood by phenol extraction. Next-generation sequencing (NGS) in the proband was performed using the TruSight One (TSO, Illumina, San Diego, California, United States) sequencing panel. Selected genetic variants identified by NGS were followed up in the proband and relatives, using Sanger sequencing. We identified the frameshift deletion p.Thr2625fs (c.7871_7872delAC), annotated to transcript NM_004415.2 of the desmoplakin (DSP) gene, in the proband, but not in his healthy mother or sister (FIGURE 1F and 1G). Desmoplakin is a critical component of desmosome structures in the cardiac muscle, and the role of DSP mutations, including protein-truncating mutations, in the pathogenesis of cardiomyopathies is well established.1,2 The identified variant has not been described in the literature before or found in genomic databases (Phase 3 of 1000 Genomes, NHLBI GO Exome Sequencing Project [ESP] 6500 and Version 0.3 of ExAC). Although the recommendation of an implantable cardioverter defibrillator (ICD) as primary prevention remains controversial,3 it was necessary in this case. ICD was implemented owing to signs of biventricular involvement on CMR, the family history of SCD, and the result of genetic study in the patient with complex ventricular arrhythmia. A 2-year follow-up revealed that the patient remained asymptomatic, and cardiac function was stable with readings from the ICD memory Sudden cardiac death (SCD) of young, apparently healthy individuals raises questions about whether other family members are also at risk of SCD. A 30-year-old patient treated with bisoprolol (5 mg once daily) for ventricular arrhythmia for 6 months was admitted to our hospital for evaluation. A family history of SCD was identified: the patient’s brother died suddenly at the age of 39 years while working at the computer. A physical examination of our patient was unremarkable. A standard 12-lead electrocardiogram showed sinus bradycardia (47 bpm) and low voltage, fragmented QRS in limb leads (FIGURE 1A). A transthoracic 2-dimensional echocardiogram revealed a nondilated left ventricle with borderline ejection fraction; however, the right ventricle was dilated with mild global contractile dysfunction. Subsequent cardiac magnetic resonance (CMR) revealed a significantly enlarged right ventricle and a slightly enlarged left ventricle (right ventricular [RV] end-diastolic volume, 151 ml/m2, n <111, and left ventricular [LV] end-diastolic volume, 111 ml/m2, n <101) with slightly reduced LV and RV ejection fractions (49% and 46%, respectively) and global hypokinesis. Additionally, diffuse changes on late gadolinium enhancement (LGE) were found (FIGURE 1B–D). On 24-hour Holter monitoring, sinus bradycardia (without pauses), single premature ventricular contractions, ventricular couplets, and episodes of nonsustained ventricular tachycardia (2 polymorphic triplets) were observed. A family history revealed that the proband’s father died of heart failure at the age of 75 years, and a paternal cousin died suddenly (FIGURE 1E). Noninvasive clinical cardiac screening was performed in Correspondence to: Prof. Zofia T. Bilińska, MD, PhD, Ośrodek Badań Przesiewowych Dziedzicznych Chorób Układu Sercowo-Naczyniowego, Instytut Kardiologii, ul. Alpejska 42, 04-628 Warszawa, Poland, phone: +48 22 343 47 11, e-mail: zbilinska@ikard.pl (for clinical issues); Prof. Rafał Płoski, MD, PhD, Zakład Genetyki Medycznej, Warszawski Uniwersytet Medyczny, ul. Pawińskiego 3c, 02-106 Warszawa, Poland, phone: +48 22 572 06 06, e-mail: rploski@wp.pl (for genetic issues) Received: July 1, 2016. Revision accepted: August 29, 2016. Published online: September 27, 2016. Conflict of interests: none declared. Pol Arch Med Wewn. 2016; 126 (9): 704-707 doi:10.20452/pamw.3567 Copyright by Medycyna Praktyczna, Kraków 2016 CLINICAL IMAGE","PeriodicalId":20343,"journal":{"name":"Polskie Archiwum Medycyny Wewnetrznej","volume":"126 9 1","pages":"704-707"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Novel truncating desmoplakin mutation as a potential cause of sudden cardiac death in a family.\",\"authors\":\"B. Foss-Nieradko, M. Franaszczyk, M. Śpiewak, A. Oreziak, R. Płoski, Z. Bilińska\",\"doi\":\"10.20452/pamw.3567\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"704 available family members (mother and sister) and revealed no abnormalities. A genetic study was performed to gain insight into SCD in the family and identify family members at potential risk. DNA was extracted from peripheral blood by phenol extraction. Next-generation sequencing (NGS) in the proband was performed using the TruSight One (TSO, Illumina, San Diego, California, United States) sequencing panel. Selected genetic variants identified by NGS were followed up in the proband and relatives, using Sanger sequencing. We identified the frameshift deletion p.Thr2625fs (c.7871_7872delAC), annotated to transcript NM_004415.2 of the desmoplakin (DSP) gene, in the proband, but not in his healthy mother or sister (FIGURE 1F and 1G). Desmoplakin is a critical component of desmosome structures in the cardiac muscle, and the role of DSP mutations, including protein-truncating mutations, in the pathogenesis of cardiomyopathies is well established.1,2 The identified variant has not been described in the literature before or found in genomic databases (Phase 3 of 1000 Genomes, NHLBI GO Exome Sequencing Project [ESP] 6500 and Version 0.3 of ExAC). Although the recommendation of an implantable cardioverter defibrillator (ICD) as primary prevention remains controversial,3 it was necessary in this case. ICD was implemented owing to signs of biventricular involvement on CMR, the family history of SCD, and the result of genetic study in the patient with complex ventricular arrhythmia. A 2-year follow-up revealed that the patient remained asymptomatic, and cardiac function was stable with readings from the ICD memory Sudden cardiac death (SCD) of young, apparently healthy individuals raises questions about whether other family members are also at risk of SCD. A 30-year-old patient treated with bisoprolol (5 mg once daily) for ventricular arrhythmia for 6 months was admitted to our hospital for evaluation. A family history of SCD was identified: the patient’s brother died suddenly at the age of 39 years while working at the computer. A physical examination of our patient was unremarkable. A standard 12-lead electrocardiogram showed sinus bradycardia (47 bpm) and low voltage, fragmented QRS in limb leads (FIGURE 1A). A transthoracic 2-dimensional echocardiogram revealed a nondilated left ventricle with borderline ejection fraction; however, the right ventricle was dilated with mild global contractile dysfunction. Subsequent cardiac magnetic resonance (CMR) revealed a significantly enlarged right ventricle and a slightly enlarged left ventricle (right ventricular [RV] end-diastolic volume, 151 ml/m2, n <111, and left ventricular [LV] end-diastolic volume, 111 ml/m2, n <101) with slightly reduced LV and RV ejection fractions (49% and 46%, respectively) and global hypokinesis. Additionally, diffuse changes on late gadolinium enhancement (LGE) were found (FIGURE 1B–D). On 24-hour Holter monitoring, sinus bradycardia (without pauses), single premature ventricular contractions, ventricular couplets, and episodes of nonsustained ventricular tachycardia (2 polymorphic triplets) were observed. A family history revealed that the proband’s father died of heart failure at the age of 75 years, and a paternal cousin died suddenly (FIGURE 1E). Noninvasive clinical cardiac screening was performed in Correspondence to: Prof. Zofia T. Bilińska, MD, PhD, Ośrodek Badań Przesiewowych Dziedzicznych Chorób Układu Sercowo-Naczyniowego, Instytut Kardiologii, ul. Alpejska 42, 04-628 Warszawa, Poland, phone: +48 22 343 47 11, e-mail: zbilinska@ikard.pl (for clinical issues); Prof. Rafał Płoski, MD, PhD, Zakład Genetyki Medycznej, Warszawski Uniwersytet Medyczny, ul. Pawińskiego 3c, 02-106 Warszawa, Poland, phone: +48 22 572 06 06, e-mail: rploski@wp.pl (for genetic issues) Received: July 1, 2016. Revision accepted: August 29, 2016. Published online: September 27, 2016. Conflict of interests: none declared. Pol Arch Med Wewn. 2016; 126 (9): 704-707 doi:10.20452/pamw.3567 Copyright by Medycyna Praktyczna, Kraków 2016 CLINICAL IMAGE\",\"PeriodicalId\":20343,\"journal\":{\"name\":\"Polskie Archiwum Medycyny Wewnetrznej\",\"volume\":\"126 9 1\",\"pages\":\"704-707\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Polskie Archiwum Medycyny Wewnetrznej\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20452/pamw.3567\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polskie Archiwum Medycyny Wewnetrznej","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20452/pamw.3567","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
704名可用家庭成员(母亲和妹妹),未发现异常。进行了一项基因研究,以深入了解SCD家族,并确定有潜在风险的家族成员。采用苯酚萃取法提取外周血DNA。先证者的下一代测序(NGS)使用TruSight One (TSO, Illumina, San Diego, California, United States)测序板进行。采用Sanger测序对先证者和亲属中经NGS鉴定的遗传变异进行随访。我们在先证者中发现移码缺失p.s thr2625fs (c.7871_7872delAC),注释到desmoplakin (DSP)基因的转录NM_004415.2,但在其健康的母亲或姐妹中没有发现(图1F和1G)。Desmoplakin是心肌桥粒结构的关键组成部分,DSP突变(包括蛋白截断突变)在心肌病发病机制中的作用已经得到了很好的证实。1,2所鉴定的变异在之前的文献中未被描述,也未在基因组数据库中发现(1000 Genomes的第3阶段,NHLBI GO Exome Sequencing Project [ESP] 6500和ExAC的0.3版本)。尽管植入式心律转复除颤器(ICD)作为一级预防的建议仍然存在争议,但在本病例中,这是必要的。考虑到CMR双心室受累的迹象、SCD的家族史以及复杂室性心律失常患者的遗传研究结果,我们实施了ICD。2年随访显示患者无症状,ICD记忆读数显示心功能稳定,年轻健康个体的心源性猝死(SCD)引发了其他家庭成员是否也有SCD风险的问题。一例30岁的室性心律失常患者接受比索洛尔(5 mg,每日1次)治疗6个月。确定了SCD的家族史:患者的兄弟在39岁时在电脑前工作时突然死亡。我们病人的体格检查没有什么特别之处。标准12导联心电图显示窦性心动过缓(47bpm)和肢体导联低电压、碎片化QRS(图1A)。经胸二维超声心动图显示左心室未扩张,射血分数边缘性;然而,右心室扩张伴轻度整体收缩功能障碍。随后的心脏磁共振(CMR)显示右心室明显增大,左心室略有增大(右心室[RV]舒张末期容积,151 ml/m2, n <111,左心室[LV]舒张末期容积,111 ml/m2, n <101),左室和右室射血分数略有降低(分别为49%和46%),全身运动不足。此外,晚期钆增强(LGE)可见弥漫性改变(图1B-D)。在24小时动态心电图监测中,观察到窦性心动过缓(无停顿)、单次室性早搏、室性联和非持续性室性心动过速发作(2例多态三胞胎)。家族史显示,先证者的父亲在75岁时死于心力衰竭,一位表兄突然死亡(图1E)。无创临床心脏筛查由Zofia T.教授Bilińska, MD, PhD, Ośrodek badawa Przesiewowych Dziedzicznych Chorób Układu sercoco - naczyniowego, institut cardiologii, ul进行。Alpejska 42, 04-628华沙,波兰,电话:+48 22 343 47 11,电子邮件:zbilinska@ikard.pl(用于临床问题);rafazov教授Płoski, MD, PhD, Zakład Genetyki Medycznej, Warszawski大学系统医学,ul。Pawińskiego 3c, 02-106华沙,波兰,电话:+48 22 572 06 06,电子邮件:rploski@wp.pl(遗传问题)收稿日期:2016年8月29日。发布日期:2016年9月27日。利益冲突:没有声明。Pol Arch Med Wewn. 2016;126 (9): 704-707 doi:10.20452/pam .3567Medycyna Praktyczna版权所有Kraków 2016 CLINICAL IMAGE
Novel truncating desmoplakin mutation as a potential cause of sudden cardiac death in a family.
704 available family members (mother and sister) and revealed no abnormalities. A genetic study was performed to gain insight into SCD in the family and identify family members at potential risk. DNA was extracted from peripheral blood by phenol extraction. Next-generation sequencing (NGS) in the proband was performed using the TruSight One (TSO, Illumina, San Diego, California, United States) sequencing panel. Selected genetic variants identified by NGS were followed up in the proband and relatives, using Sanger sequencing. We identified the frameshift deletion p.Thr2625fs (c.7871_7872delAC), annotated to transcript NM_004415.2 of the desmoplakin (DSP) gene, in the proband, but not in his healthy mother or sister (FIGURE 1F and 1G). Desmoplakin is a critical component of desmosome structures in the cardiac muscle, and the role of DSP mutations, including protein-truncating mutations, in the pathogenesis of cardiomyopathies is well established.1,2 The identified variant has not been described in the literature before or found in genomic databases (Phase 3 of 1000 Genomes, NHLBI GO Exome Sequencing Project [ESP] 6500 and Version 0.3 of ExAC). Although the recommendation of an implantable cardioverter defibrillator (ICD) as primary prevention remains controversial,3 it was necessary in this case. ICD was implemented owing to signs of biventricular involvement on CMR, the family history of SCD, and the result of genetic study in the patient with complex ventricular arrhythmia. A 2-year follow-up revealed that the patient remained asymptomatic, and cardiac function was stable with readings from the ICD memory Sudden cardiac death (SCD) of young, apparently healthy individuals raises questions about whether other family members are also at risk of SCD. A 30-year-old patient treated with bisoprolol (5 mg once daily) for ventricular arrhythmia for 6 months was admitted to our hospital for evaluation. A family history of SCD was identified: the patient’s brother died suddenly at the age of 39 years while working at the computer. A physical examination of our patient was unremarkable. A standard 12-lead electrocardiogram showed sinus bradycardia (47 bpm) and low voltage, fragmented QRS in limb leads (FIGURE 1A). A transthoracic 2-dimensional echocardiogram revealed a nondilated left ventricle with borderline ejection fraction; however, the right ventricle was dilated with mild global contractile dysfunction. Subsequent cardiac magnetic resonance (CMR) revealed a significantly enlarged right ventricle and a slightly enlarged left ventricle (right ventricular [RV] end-diastolic volume, 151 ml/m2, n <111, and left ventricular [LV] end-diastolic volume, 111 ml/m2, n <101) with slightly reduced LV and RV ejection fractions (49% and 46%, respectively) and global hypokinesis. Additionally, diffuse changes on late gadolinium enhancement (LGE) were found (FIGURE 1B–D). On 24-hour Holter monitoring, sinus bradycardia (without pauses), single premature ventricular contractions, ventricular couplets, and episodes of nonsustained ventricular tachycardia (2 polymorphic triplets) were observed. A family history revealed that the proband’s father died of heart failure at the age of 75 years, and a paternal cousin died suddenly (FIGURE 1E). Noninvasive clinical cardiac screening was performed in Correspondence to: Prof. Zofia T. Bilińska, MD, PhD, Ośrodek Badań Przesiewowych Dziedzicznych Chorób Układu Sercowo-Naczyniowego, Instytut Kardiologii, ul. Alpejska 42, 04-628 Warszawa, Poland, phone: +48 22 343 47 11, e-mail: zbilinska@ikard.pl (for clinical issues); Prof. Rafał Płoski, MD, PhD, Zakład Genetyki Medycznej, Warszawski Uniwersytet Medyczny, ul. Pawińskiego 3c, 02-106 Warszawa, Poland, phone: +48 22 572 06 06, e-mail: rploski@wp.pl (for genetic issues) Received: July 1, 2016. Revision accepted: August 29, 2016. Published online: September 27, 2016. Conflict of interests: none declared. Pol Arch Med Wewn. 2016; 126 (9): 704-707 doi:10.20452/pamw.3567 Copyright by Medycyna Praktyczna, Kraków 2016 CLINICAL IMAGE